drugset / Trial / NCT02005770

Anesthesia and Circulating Tumor Cells in Breast Cancer

NCT02005770

Phase 4 Completed 221 enrolled University of Zurich
RandomizedParallel-groupTriple-blindTreatment

Summary

Serious concern about the role of anesthesia in tumor recurrence has considerably risen over years, but the lack of surrogate markers for tumor spreading made trials addressing this issue difficult to realize. In breast cancer patients CTC positivity has been recently recognized as an independent prognostic factor. In this respect, we postulated that in a first step changes in the number of CTC after general anesthesia would help to determine the effect of anesthesia on this tumor marker.

Timeline

Start
2014-03
Primary completion
2018-04
Completion
2018-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Propofol Small molecule
Subject Sevoflurane Other / unclassified